Durvalumab after sequential chemoradiotherapy in unresectable stage III non-small-cell lung cancer - final analysis from the phase II PACIFIC-6 trial
by Garassino, Marina (Author)
, Khalifa, J. (Author)
, Reck, M. (Author)
, Chouaid, C. (Author)
, Bischoff, Helge (Author)
, Reinmuth, N. (Author)
, Cove-Smith, L. (Author)
, Mansy, T. (Author)
, Cortinovis, D. L. (Author)
, Migliorino, M. R. (Author)
, Delmonte, A. (Author)
, Garcia Sánchez, J. (Author)
, Chara Velarde, L. E. (Author)
, Bernabe, R. (Author)
, Paz-Ares, L. (Author)
, Chander, P. (Author)
, Diaz Perez, I. (Author)
, Foroutanpour, K. (Author)
, Emeribe, U. (Author)
, Faivre-Finn, C. (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource